Key Statistics
Market Cap$824.17M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$1.74
52W High$18.90
52W Low$6.66
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees163
Price Performance
1 Week+2.85%
3 Month-24.34%
1 Year-38.06%
FinancialsAnnual · QuiverQuant
Revenue$30,000
Assets$233.19M
Liabilities$2.43M
Net Income$54.37M loss
About
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine aerosol with absorption technology for patients and their families at risk of severe allergic reactions to food, medication, and insect stings. The company is headquartered in San Diego, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze SPRY with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.